Moreover, the expression of the SIRT1 mRNA and protein was decreased in lamina propria mononuclear cells from patients with IBD, while treatment with a SIRT1 activator inhibited the activation of NF-κB and the generation of proinflammatory cytokines. Here, SIRT1 is linked to inflammatory bowel disease.